SWOT Analysis
Strength: Remicade biosimilars market has strong growth potential due to the patent expiry of Remicade leading to availability of affordable treatment options. Biosimilars have almost similar efficacy as reference biologics with much lower costs. Rapid regulatory approvals for biosimilars are catalyzing their commercialization. Weakness: Development of biosimilars require...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian